← Back

Shanghai Rongtai Health Tech

Shanghai Rongtai Health Technology Corporation Limited, along with its subsidiaries, researches, develops, designs, produces, and sells massage equipment under the Rongtai and Momoda brands in China and internationally. Its offerings include massage chairs and accessories, experiential massage services, ankle revive and ROVO walking devices, small massagers, shared massage services, and smart home health gadgets such as slimming machines and beauty devices, plus purchase and after-sale services. The company also engages in software and financial activities, technology promotion and application, investment and asset management, wholesale and retail trade, e-commerce and online sales, smart home consumer devices and artificial intelligence hardware, and the research, development, manufacturing, and sales of automatic coffee machines. Products are sold through distributors, direct sales, e-commerce, experience stores, ODM, shopping mall terminals, and chain stores, and are exported. Founded in 1997, the company is based in Shanghai, China.

Country
Price · split & dividend adjusted
News & notes moving 603579.CG
China
603579.CG▲

Xinhua Winshare leads media sector with 5 consecutive limit-ups, plans to acquire Sichuan Nationalities Publishing House for 346 million yuan

On September 24, major A-share indices opened lower, while the media sector bucked the trend in early trading. Xinhua Winshare hit its fifth consecutive limit-up, Xinhua Media its fourth, and Topway Video its third, with Guangdong Media and Inner Mongolia Xinhua Distribution also among the top gainers. In news, Xinhua Winshare recently announced plans to use its own funds to acquire the 100% equity stake in Sichuan Nationalities Publishing House held by its controlling shareholder, Sichuan Xinhua Publishing and Distribution Group, for 346 million yuan. The transaction constitutes a related-party transaction but does not constitute a major asset restructuring. On the same day, Bairui Gene debuted on the Beijing Stock Exchange, opening 347.23% higher and rising more than 400% as of press time, with an issue price of 16.77 yuan. The company focuses on the research, production, and sales of biomedical materials and other products. The AI-driven drug discovery concept saw a sudden surge, with Berry Genomics hitting the daily limit-up in a straight line, and BGI Genomics, Rongtai Health, Saili Medical, Sino Biological, and Kingmed Diagnostics following higher. This came after the Ministry of Industry and Information Technology and nine other departments jointly issued the 15th Five-Year Plan for the development of the pharmaceutical industry, which explicitly calls for accelerating the use of artificial intelligence and other new technologies to empower drug research and development. The coal sector fluctuated higher, with Yunnan Coal Energy hitting the daily limit-up, briefly opening, and then sealing the limit-up again. Zhengzhou Coal Mining Machinery, Liaoning Energy, Antai Group, and Shaanxi Heimao followed higher. On September 24, the benchmark price for thermal coal on SunSirs was 989.50 yuan per ton, up 13.02% from 875.50 yuan per ton at the beginning of the month. The robotics concept saw localized movement, with Xiangyang Automobile Bearing hitting the limit-up, and Ningbo Dongli, Wanxiang Qianchao, Nanfang Precision, Sanhua Intelligent Controls, and Tuopu Group following higher. Tesla CEO Elon Musk said in an interview on September 23 that he predicts there will be at least 1 billion humanoid robots within 10 years or less, perhaps 10 billion in the next 15 years, and possibly 100 billion in the next 20 years. The real estate sector fell sharply, with Huali Family hitting the limit-down, Huayuan Holdings touching the limit-down, and Greenland Holdings, Heungkong Holdings, China Vanke, and Risesun Development quickly following lower.
0811-OL.HK · Capital · Positive Xinhua Winshare announced plans to acquire 100% of Sichuan Nationalities Publishing House for 346 million yuan, a related-party acquisition.
601811.CG · Capital · Positive Same company as Xinhua Winshare; its announced 346 million yuan acquisition of Sichuan Nationalities Publishing House is the news driving the fifth consecutive limit-up.
Sichuan Minzu Publishing House Co Ltd · Capital · Positive Xinhua Winshare plans to acquire 100% of Sichuan Nationalities Publishing House for 346 million yuan from its controlling shareholder.
Sichuan Xinhua Publishing and Distribution Group · Capital · Positive As controlling shareholder, Sichuan Xinhua Publishing and Distribution Group is selling its 100% stake in Sichuan Nationalities Publishing House for 346 million yuan.
000710.CS · Regulation · Positive Berry Genomics hit the daily limit-up as the AI-driven drug discovery concept surged after the MIIT-led 15th Five-Year Plan for pharma explicitly backed AI in drug R&D.
300676.CS · Regulation · Positive BGI Genomics rose with the AI-driven drug discovery concept after the MIIT-led 15th Five-Year Plan called for accelerating AI use in drug R&D.
Read original ↗
证券时报·11dRead more →
603579.CG▼3

Rongtai Health Releases 2026 Interim Report with Net Profit of 112 Million Yuan

Rongtai Health released its 2026 interim report, with net profit attributable to the parent company of 112 million yuan. The company's total operating revenue was 991 million yuan, and net cash flow from operating activities was negative 1.63 million yuan, down 101.81 percent from the same period last year. The latest asset-liability ratio was 28.58 percent, gross margin was 29.31 percent, ROE was 4.07 percent, and diluted earnings per share was 0.56 yuan.
603579.CG · Capital · Negative Net profit of 112 million yuan with negative operating cash flow down 101.81% year-over-year
Read original ↗
Jiemian·46dRead more →
China
603579.CG▲

Rongtai Health's first-half 2026 net profit rises 31.48% year on year

Rongtai Health released its 2026 semi-annual report, achieving operating revenue of 991 million yuan, up 22.29% year on year. Net profit attributable to shareholders of the listed company was 112 million yuan, up 31.48% year on year. Second-quarter net profit was 42 million yuan, down 39% quarter on quarter from 70 million yuan in the first quarter.
603579.CG · Capital · Positive Net profit up 31.48% year on year in H1 2026.
Read original ↗
603579.CG2

Rongtai Health Plans to Invest 250 Million Yuan in Investment Fund

Rongtai Health plans to use 250 million yuan of its own funds to jointly establish the Feike Rongtai Investment Fund Suzhou Partnership Enterprise Limited Partnership with Kane Capital and Shanghai Feike Investment Co., Ltd. The fund has a total committed capital of 500 million yuan, with Rongtai Health contributing 49.90%. This transaction constitutes a related-party transaction because Zhang Bo, a director and board secretary of the company, serves as a director at Kane Capital. The fund will focus on investing in strategic emerging sectors such as advanced manufacturing, high-end equipment, and smart hardware, prioritizing hard-tech projects that support intelligent manufacturing technology synergies and projects or enterprises in the new consumer sector.
603579.CG · Capital · Neutral Company invests 250M yuan in a fund; impact depends on fund performance, which is uncertain.
Read original ↗
财中社·91dRead more →